A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 20139913)

Published in Eye (Lond) on February 05, 2010

Authors

G B Arden1, M K Gündüz, A Kurtenbach, M Völker, E Zrenner, S B Gündüz, U Kamis, B T Oztürk, S Okudan

Author Affiliations

1: Department of Optometry and Visual Science, School of Community and Health Sciences, City University, London, UK. g.arden@city.ac.uk

Articles citing this

Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A (2013) 1.36

Regression of early diabetic macular oedema is associated with prevention of dark adaptation. Eye (Lond) (2011) 1.03

The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol (2012) 1.00

Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes. Diabetes Metab J (2014) 0.80

Spare the rods and spoil the retina: revisited. Eye (Lond) (2015) 0.79

Early local functional changes in the human diabetic retina: a global flash multifocal electroretinogram study. Graefes Arch Clin Exp Ophthalmol (2012) 0.79

A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial. Trials (2014) 0.79

Light adaptation does not prevent early retinal abnormalities in diabetic rats. Sci Rep (2016) 0.78

Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy. Am J Pathol (2016) 0.76

Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease. Eye (Lond) (2016) 0.75

Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial. Trials (2014) 0.75

Rod metabolic demand drives progression in retinopathies. Taiwan J Ophthalmol (2015) 0.75

Articles by these authors

(truncated to the top 100)

Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (2000) 4.95

Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet (1997) 4.48

Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res (1994) 4.30

Guidelines for basic pattern electroretinography. Recommendations by the International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1997) 3.66

A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet (1996) 3.31

Standard for clinical electroretinography (1994 update). Doc Ophthalmol (1995) 2.94

Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet (1998) 2.63

CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51

An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.48

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1993) 2.46

Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci (2000) 2.46

Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc Natl Acad Sci U S A (1999) 2.46

New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet (2001) 2.44

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Arch Ophthalmol (1993) 2.20

Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet (2000) 2.20

Experiences with the international standard for clinical electroretinography: normative values for clinical practice, interindividual and intraindividual variations and possible extensions. Doc Ophthalmol (1993) 2.03

Electrical multisite stimulation of the isolated chicken retina. Vision Res (2000) 1.82

Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein. Am J Clin Nutr (1999) 1.65

Inter-individual variability in the dynamics of natural accommodation in humans: relation to age and refractive errors. J Physiol (1993) 1.60

Hepatic retinopathia. Changes in retinal function. Vision Res (1997) 1.58

OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet (2001) 1.54

Retinal prosthesis: an encouraging first decade with major challenges ahead. Ophthalmology (2001) 1.48

Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet (1993) 1.47

Enchancement of luminance flicker by color-opponent mechanisms. Science (1979) 1.46

Evaluation of the rhodopsin knockout mouse as a model of pure cone function. Invest Ophthalmol Vis Sci (2001) 1.40

Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol (2008) 1.39

Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci (1999) 1.36

Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol (2000) 1.35

Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol (1998) 1.34

Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol (2002) 1.28

Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum Mol Genet (1997) 1.27

Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. Am J Hum Genet (1992) 1.27

Constant light affects retinal dopamine levels and blocks deprivation myopia but not lens-induced refractive errors in chickens. Vis Neurosci (1994) 1.24

Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat (1999) 1.22

The role of the peripherin/RDS gene in retinal dystrophies. Acta Anat (Basel) (1998) 1.20

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19

6-Hydroxy dopamine does not affect lens-induced refractive errors but suppresses deprivation myopia. Vision Res (1994) 1.19

Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol (1992) 1.18

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 1.16

Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens. Vision Res (1995) 1.16

Human rod monochromacy: linkage analysis and mapping of a cone photoreceptor expressed candidate gene on chromosome 2q11. Genomics (1998) 1.15

Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1994) 1.15

Clinical applications of multifocal electroretinography. Doc Ophthalmol (2000) 1.11

Is colour vision possible with only rods and blue-sensitive cones? Nature (1991) 1.11

Multifocal electroretinography in patients with Stargardt's macular dystrophy. Br J Ophthalmol (1998) 1.11

RDS/peripherin gene mutations are frequent causes of central retinal dystrophies. J Med Genet (1997) 1.09

Pupil perimetry using M-sequence stimulation technique. Invest Ophthalmol Vis Sci (2000) 1.08

Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy. Biochem Biophys Res Commun (1997) 1.07

Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med (2012) 1.07

Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene. Invest Ophthalmol Vis Sci (2001) 1.05

Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci (2001) 1.03

Diurnal control of rod function in the chicken. Vis Neurosci (1991) 1.03

Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. Am J Hum Genet (1992) 1.02

Cone and rod function in cone degenerations. Vision Res (1997) 1.02

A 16 kDa protein co-isolating with gap junctions from brain tissue belonging to the class of proteolipids of the vacuolar H+-ATPases. FEBS Lett (1989) 1.02

Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea (1995) 0.99

Spatial cone activity distribution in diseases of the posterior pole determined by multifocal electroretinography. Vision Res (1998) 0.99

Slow and fast pathways in the human rod visual system: electrophysiology and psychophysics. J Opt Soc Am A (1991) 0.99

Long-term survival of retinal cell cultures on retinal implant materials. Vision Res (1999) 0.98

Cloning, chromosomal localization and functional expression of the gene encoding the alpha-subunit of the cGMP-gated channel in human cone photoreceptors. Eur J Neurosci (1997) 0.98

A genetic perspective on myopia. Cell Mol Life Sci (2005) 0.97

Current source density analysis of linear and non-linear components of the primate electroretinogram. J Physiol (1988) 0.97

Studies on the feasibility of a subretinal visual prosthesis: data from Yucatan micropig and rabbit. Graefes Arch Clin Exp Ophthalmol (2001) 0.97

The photoreceptors in atypical achromatopsia. J Physiol (1989) 0.96

Characteristics of the blue sensitive cone mechanism in primate retinal ganglion cells. Vision Res (1981) 0.95

Effects of ethyl alcohol on the electrooculogram and color vision. Doc Ophthalmol (1986) 0.95

Mutations in the human peripherin/RDS gene associated with autosomal dominant retinitis pigmentosa. Hum Mutat (1994) 0.95

Extensive intrafamilial and interfamilial phenotypic variation among patients with autosomal dominant retinal dystrophy and mutations in the human RDS/peripherin gene. Br J Ophthalmol (1995) 0.95

[Subretinal visual implants]. Klin Monbl Augenheilkd (2010) 0.95

Evaluation of the Night Vision Spectacles on patients with impaired night vision. Graefes Arch Clin Exp Ophthalmol (1999) 0.94

Dynamic noise backgrounds facilitate target fading. Vision Res (1992) 0.94

Implicit time topography of multifocal electroretinograms. Invest Ophthalmol Vis Sci (1998) 0.93

Deletions in exon 5 of the human rhodopsin gene causing a shift in the reading frame and autosomal dominant retinitis pigmentosa. Hum Genet (1992) 0.93

Mizuo phenomenon in X-linked retinoschisis. Pathogenesis of the Mizuo phenomenon. Arch Ophthalmol (1991) 0.93

Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (2005) 0.92

A proposal for the documentation of clinically applied color vision tests. Dev Ophthalmol (1984) 0.92

GPR98 mutations cause Usher syndrome type 2 in males. J Med Genet (2009) 0.91

["Oligocone" trichromasy, a rare form of incomplete achromatopsia]. Ophthalmologe (1997) 0.91

Temporal properties of marmoset lateral geniculate cells. Vision Res (1997) 0.91

Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci (2000) 0.91

The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat. Invest Ophthalmol Vis Sci (1986) 0.91

Identification of Usher syndrome subtypes by ERG implicit time. Invest Ophthalmol Vis Sci (2001) 0.91

In vitro identification of retinal ganglion cells in culture without the need of dye labeling. J Neurosci Methods (1994) 0.90

Retinoschisislike alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest Ophthalmol Vis Sci (1997) 0.90

[Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives]. Ophthalmologe (2012) 0.90

[Status of the subretinal implant project. An overview]. Ophthalmologe (2005) 0.89

Effect of altered eating habits and periods during Ramadan fasting on intraocular pressure, tear secretion, corneal and anterior chamber parameters. Eye (Lond) (2009) 0.89

Off-components in response to brief light flashes in the oscillatory potential of the human electroretinogram. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.89

Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin. Br J Ophthalmol (1993) 0.89

Longitudinal chromatic aberration and emmetropization: results from the chicken eye. J Physiol (1992) 0.89

Analysis of 21 Stargardt's disease families confirms a major locus on chromosome 1p with evidence for non-allelic heterogeneity in a minority of cases. Br J Ophthalmol (1996) 0.89

Asymmetries in the time-course of chromatic adaptation and the significance of contrast. Vision Res (2000) 0.88

A novel mutation of the RP1 gene (Lys778ter) associated with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (2002) 0.88

Brightness matching and colour discrimination in young diabetics without retinopathy. Vision Res (1994) 0.88

Electroretinographic campimetry in a patient with crystalline retinopathy. Ger J Ophthalmol (1996) 0.88

["Glare vision". I. Physiological principles of vision change with increased test field luminance]. Klin Monbl Augenheilkd (1992) 0.87

Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci (1997) 0.87

Linkage of X-linked retinitis pigmentosa to the hypervariable DNA marker M27 beta (DXS255). Hum Genet (1989) 0.87

Prognostic value of the pattern electroretinogram in cases of tumors affecting the optic pathway. Graefes Arch Clin Exp Ophthalmol (1998) 0.86

[Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema]. Ophthalmologe (2004) 0.86